Table II.

Tower of London

	R/L	Chemo group				Control group				Chemo < control group				Voxels
		x	y	z	Z value	x	y	z	Z value	x	y	z	Z value
Dorsolateral PFC	R	48	27	36	4.17	30	36	42	5.62
	L	−48	18	45	4.36	−48	27	33	5.06	−48	6	39	3.25	16a
Ventrolateral PFC	R	36	57	3	3.73	48	42	−9	3.36
	L	−48	42	−6	3.69	−45	48	−3	3.94
Premotor cortex	R	30	21	45	4.13	27	21	45	5.01
	L	−27	21	48	4.02	−27	21	48	5.30
	L	−6	27	54	5.11	−6	27	45	5.40
Precuneus	R	9	−72	54	5.71	9	−72	54	6.73
	L	−9	−60	57	4.92	−9	−60	57	5.72
PPC	R	51	−45	51	4.73	51	−45	51	5.90	39	−60	54	3.94	17
										48	−33	48	3.83	16
	L	−45	−51	45	4.70	−33	−75	48	5.63	−30	−60	57	3.43	10
Dorsal striatum	R	15	−3	18	3.27	12	−6	18	4.08
	L	−9	−3	15	3.70	−9	0	12	4.15
Inferior temporal G	R	54	−63	−12	3.40	54	−63	−9	4.90
	L	−57	−60	−3	5.00	−57	−57	−3	5.38
Occipital cortex	R	15	−54	21	4.02	15	−60	21	4.11
	L	−15	−63	24	3.31	−15	−60	21	3.45

BOLD activations (MNI coordinates) for the Active > Baseline contrast for breast cancer survivors after chemotherapy (Chemo Group), breast cancer survivors without chemotherapy (Control Group) and group interactions.

Abbreviations: R, right; L, left; PFC, prefrontal cortex; PPC, lateral posterior parietal cortex; G, gyrus. Main task effects for each group are reported at P < 0.05, FDR corrected. Group interactions are reported at P < 0.001 unless indicated otherwise.

^aROI analysis at P < 0.005 uncorrected.